NCT01221480已完成不适用
Beta-Blockers Reduce Mortality and Exacerbations When Added to Stepwise Inhaled Therapy for COPD Without Adverse Effects on Lung Function.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 5,977
- 主要终点
- All-cause Mortality
研究概览
简要总结
The aim of this observational study is to utilise the established record linkage data available in Tayside to investigate hospital admissions, exacerbations and mortality in COPD.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 50 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Data collected through TARDIS database
排除标准
- •History of asthma or malignancy. Less than 50 years of age
结局指标
主要结局
All-cause Mortality
时间窗: 3000 days
All-cause Mortality
次要结局
- Hospital Admissions(3000 days)
- COPD exacerbations(3000 days)
研究者
相似试验
Unknown
不适用
Collaborative Systematic Overview of Randomised Controlled Trials of Beta-Blockers in the Treatment of Heart FailureHeart FailureNCT00832442Royal Brompton & Harefield NHS Foundation Trust18,240
Unknown
不适用
Association of Beta-Blocker Therapy at Discharge With Clinical Outcomes in Patients With Actue Coronary SyndromeActue Coronary SyndromeNCT03658577Shenzhen People's Hospital582
已完成
不适用
β Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart FailureAcute Myocardial InfarctionNCT02786654University of Leeds179,810
已完成
4 期
Beta Blockade in in Traumatic Brain InjuryBrain Injuries, TraumaticNCT02957331University of Tennessee26
已完成
不适用
The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)Myocardial InfarctionNCT00430612Northwestern University7,057